Effect of erythromycin on image quality and transit time of capsule endoscopy: A two-center study

Table 1 Demographic and clinical data of the study patients (n = 100)

Parameter	No erythromycin	Erythromycin	P
	(n = 50)	(n = 50)
Age, yr (mean ± SD)	51.7 ± 21.6	52.1 ± 19.4	0.931
Male/Female	32/18	36/14	0.39
Indications			0.40
Suspected Crohn’s	19	18	0.84
Obscure GI bleeding	23	28	0.32
Others2	8	4	0.22
Final diagnosis in SB			0.10
Normal findings	23	19	0.42
Non-specific findings	9	7	0.59
Crohn’s disease	1	7	0.06
Angiodysplasia	7	2	0.16
Polyps	1	3	0.62
Others2	9	12	0.46

¹Unpaired t-test;

²Includes Indication (abdominal pain, celiac and polyposis syndrome) and final diagnosis (nodular hyperplasia, edematous fold, etc); the rest of P values are according to nonparametric Mann-Whitney test. SB: Small bowel; GI: Gastrointestinal.